Bharat Biotech submits Covaxin phase 3 trial data to DGCI before meeting with WHO
New Delhi: Amid concerns over the effectiveness of Covid vaccines, the Hyderabad-based Bharat Biotech has submitted phase III trial data of Covaxin to Drugs Controller General of India (DCGI).
Phase-III trial data is also required for…
Read More...
Read More...